Author:
VINAYA VINOD SHINDE ,SAKSHI CHAUDHARY ,PARMINDER KAUR ,SWATI BANKARIYA
Abstract
Objectives: Human papillomavirus (HPV) is a highly oncogenic virus responsible for the majority of intraepithelial lesions and cervical cancer. Among various HPV types, 16 and 18 contribute to approximately 70% of cervical cancer cases globally, making them the most prevalent high-risk oncogenic variants associated with this disease. Numerous vaccines (Gardasil 9, Gardasil, and Cervarix) have been approved by FDA to combat HPV infections; however, their widespread implementation faces challenges due to their limited cost-effectiveness.
Methods: Echinacea purpurea’s components have already been studied for in silico analysis against HPV Type 16’s L1 protein. In the present analysis, we aimed to explore the potential interaction between E. purpurea phytoligands (curcumin, echinacoside, and chicoric acid) and the major capsid protein L1 of HPV type 18 (2R5I) through molecular docking analysis.
Results: Molecular docking analysis revealed that the echinacoside, one of the components of E. purpurea, has the best binding affinity (−7.9 kcaL/moL) against the L1 protein of the HPV type 18.
Conclusion: The molecular docking analysis indicates that E. purpurea could act as an inhibitor against HPV infection. Further research and in vivo studies are necessary to confirm its efficacy as a cost-effective alternative to present HPV vaccines.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference14 articles.
1. Chen AA, Gheit T, Franceschi S, Tommasino M, Clifford GM. Human papillomavirus 18 genetic variation and cervical cancer risk worldwide. J Virol 2015;89:10680-7.
2. Ahmed HG, Bensumaidea SH, Alshammari FD, Alenazi FS, ALmutlaq BA, Alturkstani MZ, et al. Prevalence of human papillomavirus subtypes 16 and 18 among Yemeni patients with cervical cancer. Asian Pac J Cancer Prev 2017;18:1543-8.
3. Temesgen MM, Alemu T, Shiferaw B, Legesse S, Zeru T, Haile M, et al. Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia. PLoS One 2021;16:e0248949. 4. Wang X, Liu H, Ge H, Ajiro M, Sharma NR, Meyers C, et al. Viral DNA replication orientation and hnRNPs regulate transcription of the human papillomavirus 18 late promoter. mBio 2017;8:e00713-17. 5. Lukman Y, Bala DA, Malik KI, Saidu A, Saleh KA, Abubakar BJ, et al. Identification of HPV16’s E6 gene in suspected cases of cervical lesions and docking study of its L1 protein with active components of Echinacea purpurea. Afr Health Sci 2022;22:98-105.
4. Ozbun MA. Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry. Papillomavirus Res 2019;7:188-92.
5. Barrett B. Medicinal properties of Echinacea: A critical review. Phytomedicine 2003;10:66-86.